The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Volume Progression in Autosomal Dominant Polycystic Kidney Disease: The Major Factor Determining Clinical Outcomes
Abstract
Autosomal dominant polycystic kidney disease (PKD) is a hereditary condition characterized by the progressive enlargement of innumerable renal cysts that contribute to life-altering morbidity early in the course of the disease. Evidence indicates that the rate of increase in kidney volume can be reliably measured by magnetic resonance or computed tomography imaging, thus providing objective means to judge the effectiveness of therapies that are targeted to the aberrant growth of renal tubules. It is now possible, therefore, to monitor the effectiveness of potential therapies on the signature abnormality in autosomal dominant PKD before irreversible damage has been done by the cysts. Evidence accumulated from human cross-sectional and longitudinal studies and longitudinal studies of PKD models in animals provide strong support for the view that reducing the rate of kidney volume enlargement will ameliorate the late-stage development of renal insufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Kidney: Physiology and Pathophysiology
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-544_3 · Cited by 1,673
Autosomal Dominant Polycystic Kidney Disease
Gabow, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290508 · Cited by 974
Wilson, P. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022161 · Cited by 916
Gattone, V. H., Wang, X., Harris, P. C., & Torres, V. E. (2003) · Nature Medicine · doi:10.1038/nm935 · Cited by 670
Self-citationComparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Gabow, P. A., Johnson, A. M., Kaehny, W. D., Kimberling, W. J., Lezotte, D. C., Duley, I. T., & Jones, R. H. (1992) · Kidney International · doi:10.1038/ki.1992.195 · Cited by 509
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
Torres, V. E., Wang, X., Qian, Q., Somlo, S., Harris, P. C., & Gattone, V. H. (2004) · Nature Medicine · doi:10.1038/nm1004 · Cited by 482
Self-citationDalgaard, O. Z. (1957) · PubMed · Cited by 426
Chapman, A. B., Guay-Woodford, L. M., Grantham, J. J., Torres, V. E., Bae, K. T., Baumgarten, D. A., Kenney, P. J., King, B. F., Glockner, J. F., Wetzel, L. H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00185.x · Cited by 413
Self-citationCyst formation and growth in autosomal dominant polycystic kidney disease
Grantham, J. J., Geiser, J. L., & Evan, A. P. (1987) · Kidney International · doi:10.1038/ki.1987.121 · Cited by 329
Self-citationApoptosis and Loss of Renal Tissue in Polycystic Kidney Diseases
Woo, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330104 · Cited by 317
Ruggenenti, P., Remuzzi, A., Ondei, P., Fasolini, G., Antiga, L., Ene-Iordache, B., Remuzzi, G., & Epstein, F. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00395.x · Cited by 270
Molecular pathogenesis of ADPKD: The polycystin complex gets complex
Ong, A. C. M., & Harris, P. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00201.x · Cited by 242
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.
Chapman, A. B., Johnson, A. M., Gabow, P. A., & Schrier, R. W. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v561349 · Cited by 235
Self-citationRenal structure and hypertension in autosomal dominant polycystic kidney disease
Gabow, P. A., Chapman, A. B., Johnson, A. M., Tangel, D. J., Duley, I. T., Kaehny, W. D., Manco-Johnson, M., & Schrier, R. W. (1990) · Kidney International · doi:10.1038/ki.1990.330 · Cited by 225
Self-citationTreatment of polycystic kidney disease with a novel tyrosine kinase inhibitor
Sweeney, W. E., Chen, Y., Nakanishi, K., Frost, P., & Avner, E. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00829.x · Cited by 219
American Society of Nephrology Renal Research Report
(2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030285 · Cited by 215
Johnson, A. M., & Gabow, P. A. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8101560 · Cited by 202
Characteristics of very early onset autosomal dominant polycystic kidney disease.
Fick, G. M., Johnson, A. M., Strain, J. D., Kimberling, W. J., Kumar, S., Manco-Johnson, M. L., Duley, I. T., & Gabow, P. A. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v3121863 · Cited by 189
BILATERAL POLYCYSTIC DISEASE OF THE KIDNEYS
DALGAARD, O. Z. (1959) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195904000-00016 · Cited by 181
Polycystic Kidney Disease: Prospective Analysis of Nonazotemic Patients and Family Members
GABOW, P. A., IKLÉ, D. W., & HOLMES, J. H. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-2-238 · Cited by 180
Renal Stone Disease in Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Wilson, D. M., Hattery, R. R., & Segura, J. W. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80922-x · Cited by 178
Self-citationFick-Brosnahan, G. M., Belz, M. M., McFann, K. K., Johnson, A. M., & Schrier, R. W. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33379 · Cited by 178
Polycystic Kidney Disease: Neoplasia in Disguise
Grantham, J. J. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80507-5 · Cited by 169
Self-citationPain management in polycystic kidney disease
Bajwa, Z. H., Gupta, S. K., Warfield, C. A., & Steinman, T. I. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00985.x · Cited by 169
Renal histology in polycystic kidney disease with incipient and advanced renal failure
Zeier, M., Fehrenbach, P., Geberth, S., Möhring, K., Waldherr, R., & Ritz, E. (1992) · Kidney International · doi:10.1038/ki.1992.413 · Cited by 167
Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease
Magistroni, R., He, N., Wang, K., Andrew, R., Johnson, A., Gabow, P. A., Dicks, E. L., Parfrey, P. S., Torrá, R., San‐Millán, J. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000061774.90975.25 · Cited by 157
Grantham, J. J. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90378-9 · Cited by 153
Self-citationAutosomal dominant polycystic kidney disease in childhood: A longitudinal study
Sedman, A. B., Bell, P., Manco‐Johnson, M. J., Schrier, R. W., Warady, B. A., Heard, E. O., Butler–Simon, N., & Gabow, P. A. (1987) · Kidney International · doi:10.1038/ki.1987.98 · Cited by 151
Rate of functional deterioration in polycystic kidney disease
Franz, K. A., & Reubi, F. C. (1983) · Kidney International · doi:10.1038/ki.1983.51 · Cited by 145
Pain patterns in patients with polycystic kidney disease
Bajwa, Z. H., Sial, K. A., Malik, A. B., & Steinman, T. I. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00921.x · Cited by 143
Gattone, V. H., Maser, R. L., Tian, C., Rosenberg, J. M., & Branden, M. G. (1999) · Developmental Genetics · Cited by 141
Kelleher, C. L., McFann, K. K., JOHNSON, A., & Schrier, R. W. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.020 · Cited by 140
Angiogenesis in autosomal-dominant polycystic kidney disease
Bello-Reuss, E. N., Holubec, K., & Rajaraman, S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00768.x · Cited by 138
Prognosis of adult onset polycystic kidney disease re-evaluated
Churchill, D. N., Bear, J. C., Morgan, J. M., Payne, R. H., McManamon, P. J., & GAULT, M. H. (1984) · Kidney International · doi:10.1038/ki.1984.154 · Cited by 138
Zheng, D., Wolfe, M., Cowley, B. D., Wallace, D. P., Yamaguchi, T., & Grantham, J. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088720.61783.19 · Cited by 138
Self-citationEpidemiological study of kidney survival in autosomal dominant polycystic kidney disease
Schrier, R. W., McFann, K. K., & Johnson, A. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00776.x · Cited by 136
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
Torres, V. E., Sweeney, W. E., Wang, X., Qian, Q., Harris, P. C., Frost, P., & Avner, E. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00256.x · Cited by 135
Self-citationThe Association of Nephrolithiasis and Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Erickson, S. B., Smith, L. H., Wilson, D. M., Hattery, R. R., & Segura, J. W. (1988) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(88)80137-9 · Cited by 130
Self-citationPolycystic kidney disease: Etiology, pathogenesis, and treatment
Martinez, J. R., & Grantham, J. J. (1995) · Disease-a-Month · doi:10.1016/s0011-5029(05)80007-0 · Cited by 126
Self-citationKing, B. F., Reed, J. E., Bergstralh, E. J., Sheedy, P. F., & Torres, V. E. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181505 · Cited by 125
Self-citationCONGENITAL POLYCYSTIC DISEASE OF THE KIDNEY: REVIEW OF THE LITERATUHE, AND DATA ON 207 CASES
Ball, J. E., & Odel, H. M. (1949) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194910000-00007 · Cited by 125
Renal infection in autosomal dominant polycystic kidney disease
Schwab, S. J., Bander, S. J., & Klahr, S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90005-2 · Cited by 122
Dunn, M. D., Portis, A. J., Elbahnasy, A. M., Shalhav, A. L., Rothstein, M., McDougall, E. M., & Clayman, R. V. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70021-7 · Cited by 120
Grampsas, S. A., Chandhoke, P. S., Fan, J., Glass, M. A., Townsend, R. R., Johnson, A. M., & Gabow, P. A. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8266 · Cited by 116
Renal Infections in Autosomal Dominant Polycystic Kidney Disease
Sklar, A. H., Caruana, R. J., Lammers, J. E., & Strauser, G. D. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80036-7 · Cited by 116
Cyst decompression surgery for autosomal dominant polycystic kidney disease.
Elzinga, L. W., Barry, J. M., Torres, V. E., Zincke, H., Wahner, H. W., Swan, S. K., & Bennett, W. M. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v271219 · Cited by 101
Self-citationSeeman, T., Dušek, J., Vondřichová, H., Kynčl, M., John, U., Misselwitz, J., & Janda, J. (2003) · Blood Pressure Monitoring · doi:10.1097/00126097-200306000-00003 · Cited by 100
Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
Chapman, A. B., & Schrier, R. W. (1991) · PubMed · Cited by 97
Self-citationReduction of Cyst Volume for Symptomatic Management of Autosomal Dominant Polycystic Kidney Disease
Bennett, W. M., Elzinga, L. W., Golper, T. A., & Barry, J. M. (1987) · The Journal of Urology · doi:10.1016/s0022-5347(17)44156-5 · Cited by 96
Autosomal Dominant Polycystic Kidney Disease: Symptoms and Clinical Findings
Milutinovic, J., Fialkow, P. J., Agodoa, L. Y. C., Phillips, L. A., Rudd, T. G., & Bryant, J. I. (1984) · QJM · doi:10.1093/oxfordjournals.qjmed.a067821 · Cited by 93
Mechanisms of progression in autosomal dominant polycystic kidney disease.
Grantham, J. J. (1997) · PubMed · Cited by 92
Self-citationSimon, H. B., & Thompson, G. D. (1955) · JAMA · doi:10.1001/jama.1955.02960240023006 · Cited by 90
Sweeney, W. E., Hamahira, K., Sweeney, J., Garcia-Gatrell, M., Frost, P., & Avner, E. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00232.x · Cited by 81
Sise, C. B., Kusaka, M., Wetzel, L. H., Winklhofer, F. T., Cowley, B. D., Cook, L. T., Gordon, M. A., & Grantham, J. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00433.x · Cited by 78
Self-citationA novel inhibitor of tumor necrosis factor-α converting enzyme ameliorates polycystic kidney disease
Dell, K. M., Nemo, R., Sweeney, W. E., Levin, J. I., Frost, P., & Avner, E. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00963.x · Cited by 71
Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats
Aukema, H. M., & Housini, I. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00465.x · Cited by 69
Seeman, T., Dušek, J., Vondrák, K., Bláhová, K., Šimková, E., Kreisinger, J., Dvořák, P., Kynčl, M., Hříbal, Z., & Janda, J. (2006) · Physiological Research · doi:10.33549/physiolres.930528 · Cited by 69
Levine, E., & Grantham, J. J. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.159.1.1609726 · Cited by 69
Self-citationc-myc antisense oligonucleotide treatment ameliorates murine ARPKD
Ricker, J. L., Mata, J. E., Iversen, P. L., & Gattone, V. H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.0610s1125.x · Cited by 57
Ciprofloxacin activity in cyst fluid from polycystic kidneys
Elzinga, L. W., Golper, T. A., Rashad, A. L., Carr, M. E., & Bennett, W. M. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.844 · Cited by 55
Muther, R. S., & Bennett, W. M. (1981) · Kidney International · doi:10.1038/ki.1981.170 · Cited by 52
pH-Dependent Accumulation of Clindamycin in a Polycystic Kidney
Schwab, S., Hinthorn, D. R., Diederich, D. A., Cuppage, F. E., & Grantham, J. J. (1983) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(83)80012-2 · Cited by 49
Self-citationBlood pressure and renal function in autosomal dominant polycystic kidney disease
Seeman, T., Sikut, M., Konrad, M., Vondřichová, H., Janda, J., & Scharer, K. (1997) · Pediatric Nephrology · doi:10.1007/s004670050343 · Cited by 47
Cystic Disease in Women: Clinical Characteristics and Medical Management
Chapman, A. B. (2003) · Advances in Renal Replacement Therapy · doi:10.1053/jarr.2003.50005 · Cited by 46
Self-citationLee, D. I., Andreoni, C., Rehman, J., Landman, J., Ragab, M. M., Yan, Y., Chen, C. Y.-H., Shindel, A. W., Middleton, W. D., Shalhav, A. L., et al. (2003) · Journal of Endourology · doi:10.1089/089277903767923100 · Cited by 43
Hypertension and renal injury in experimental polycystic kidney disease
Kennefick, T. M., Alnimri, M., Oyama, T., Thompson, M. M., Kelly, F. J., Chapman, J. G., & Anderson, S. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00783.x · Cited by 38
Chapman, A. B., Thickman, D., & Gabow, P. A. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)81025-0 · Cited by 34
Self-citationSchwab, S. J., & Weaver, M. E. (1986) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(86)80094-4 · Cited by 27
Polycystic Kidney Disease: An Unrecognized Emerging Infectious Disease?
Miller-Hjelle, M. A., Hjelle, J. T., Jones, M., Mayberry, W. R., Dombrink-Kurtzman, M. A., Peterson, S. W., Nowak, D. M., & Darras, F. (1997) · Emerging infectious diseases · doi:10.3201/eid0302.970204 · Cited by 14
Expression of the orpk disease gene during kidney development and maturation
Nakanishi, K., Sweeney, W. E., Avner, E. D., & Murcia, N. S. (2001) · Pediatric Nephrology · doi:10.1007/s004670000528 · Cited by 9
Cited by
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Grantham, J. J., Higashihara, E., Perrone, R. D., Krasa, H. B., Ouyang, J., & Czerwiec, F. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205511 · Cited by 1,614
Self-citationAutosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationVolume Progression in Polycystic Kidney Disease
Grantham, J. J., Torres, V. E., Chapman, A. B., Guay-Woodford, L. M., Bae, K. T., King, B. F., Wetzel, L. H., Baumgarten, D. A., Kenney, P. J., Harris, P. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054341 · Cited by 807
Self-citationBergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationGlomerular hyperfiltration: definitions, mechanisms and clinical implications
Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.19 · Cited by 673
Metadata
- Authors
- Grantham, J. J., Chapman, A. B., & Torres, V. E.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2006-01
- Volume
- 1
- Issue
- 1
- Pages
- 148-157
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2129253605
- Cited by
- 278
- References
- 71
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.